Company Analysis

Enliven Therapeutics, Inc. (ELVN)

Nasdaq: ELVN · Pharmaceutical Preparations · Boulder, CO · filing with the SEC since 2016
Grade4.9
◀ Past 4.2● Present 5.6▶ Future 4.8
6 est.

Who runs Enliven Therapeutics, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Ballal Rahul D.
Chief Executive Officer. First filing Mar 2020, latest Feb 17, 2026, 9 filings in all.
Officers reporting now
7
of 17 people with a filing in the last fifteen months
Directors reporting now
10
34 people on the record since 2020
Officerssales are open-market, Nov 3, 2025 to Nov 3, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Hohl BenjaminCHIEF FINANCIAL OFFICERFeb 2023Oct 21, 202615 · $1.8M
Collins Helen LouiseCHIEF MEDICAL OFFICERFeb 2023Oct 21, 202625 · $5.6M
Ballal Rahul D.Chief Executive OfficerMar 2020Feb 17, 2026none
Patel AnishCHIEF OPERATING OFFICERFeb 2023Feb 17, 20266 · $1.6M
Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICERFeb 2023Feb 17, 202610 · $4.5M
Fair Richard A.PRESIDENT AND CEODec 2025Dec 12, 2025none
Kintz SamuelPRESIDENT AND CEOFeb 2023Nov 19, 20251 · $300,000
Directorssales are open-market, Nov 3, 2025 to Nov 3, 2026
NameRoleFirst filingLatest filingSales, 12 months
Kunkel Lori AnnedirectorApr 2024Nov 3, 20265 · $900,000
Ball Kristine MdirectorOct 2026Oct 16, 2026none
Garland J. ScottdirectorJan 2026Oct 5, 20261 · $600,000
Derynck Mika KdirectorFeb 2023Aug 6, 20261 · $9.6M
Orbimed Advisors LLCdirectorMar 2020Jun 24, 20266 · $51.7M
Orbimed Capital Gp Vii LLCdirectorMar 2020Jun 24, 2026none
Orbimed Genesis Gp LLCdirectorFeb 2023Jun 24, 2026none
Heyman Richard A.directorFeb 2023Feb 19, 20266 · $400,000
Bauer JakedirectorFeb 2023Feb 17, 2026none
Gupta RishidirectorFeb 2023Feb 17, 2026none
Earlier names on the record37, newest filing first
Phillips Andrew John · director · last filing Feb 2025Schwab Andrew J. · director · last filing Feb 20245am Opportunities I (Gp), LLC · 10% owner · last filing Feb 20245am Opportunities I, L.P. · 10% owner · last filing Feb 20245am Partners Vi, LLC · 10% owner · last filing Feb 20245am Ventures Vi, L.P. · 10% owner · last filing Feb 2024Parmar Kush · 10% owner · last filing Feb 2024Commodore Capital LP · 10% owner · last filing Feb 2023Kolchinsky Peter · 10% owner · last filing Feb 2023Ra Capital Healthcare Fund LP · 10% owner · last filing Feb 2023Ra Capital Management, L.P. · 10% owner · last filing Feb 2023Shah Rajeev M. · 10% owner · last filing Feb 2023Gray Michael · officer · last filing Feb 2023Leonard Braden Michael · 10% owner · last filing Jan 2023Bonita David P · director · last filing Jun 2022Chin Mark · director · last filing Jun 2022Conner Edward R. · director · last filing Jun 2022Dalton Barbara · director · last filing Jun 2022Goldfischer Carl · director · last filing Jun 2022Mott David M · director · last filing Jun 2022Williams Laura A · director · last filing Jun 2022Florence Anthony A. Jr. · director · last filing Apr 2022Baskett Forest · 10% owner · last filing Apr 2022Kerins Patrick J · 10% owner · last filing Apr 2022Nea 14 Gp, Ltd · 10% owner · last filing Apr 2022Nea Partners 14, L.P. · 10% owner · last filing Apr 2022New Enterprise Associates 14, L.P. · 10% owner · last filing Apr 2022Sandell Scott D · 10% owner · last filing Apr 2022Sonsini Peter W. · 10% owner · last filing Apr 2022Attie Kenneth · officer · last filing Feb 2022Orbimed Capital LLC · director · last filing Jul 2021Nayeem Sara M. · director · last filing Jun 2021Agger Mette Kirstine · director · last filing Mar 2020Mcarthur James G · director · last filing Mar 2020Alexandria Venture Investments, LLC · 10% owner · last filing Mar 2020Arix Bioscience Holdings Ltd · 10% owner · last filing Mar 2020Scheele Willem · officer · last filing Mar 2020

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton ELVN · research, not advice